Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hah! What?! I don't mean to be critical, but Keith, the public looks to you and others within your organization to convince the FDA to decide in your favor. Well, you know, maybe the ancillary work products like clinical trials and documented WRD will do the trick. You know, one could interpret this tweet as a sign of weakness. With the upcoming, May 29th, (slam dunk) meeting, this is not the kind of public shout-out I would expect to get from a BIEL executive. I don't know, maybe I'm reading too much in to this!
Oh, well! Go! BIEL!
GLTA!!!
I wonder how long it took for this company to get its product approved by the FDA? Just a thought!
GLTA!!!
P.S. Maybe someone should investigate that question!
Great feedback! Yes, the concerns regarding use proximity to women's reproduction area is oh, so important. By all means, when applying any medical treatment method in that area of the body, exhaustive research and utmost precautions must be taken, IMO. Again, Great Feedback!
GLTA!!!
Simply put, IMHO, I don't think we should be concerned about the PPS at the moment. Lets wait until after the May 29th meeting and see what it may wrought, then go from there. If what is expected to transpire during that meeting actually happens, then this brief lull in prosperity, and indeed years of disappointment for some, will soon be a faded memory.
BIELY!, BIELY!
GLTA!!!
The FDA needs to explain why the Allay product, particularly, is not already cleared for OTC. It makes no sense! Menstrual period pain is a bane for a lot of women everywhere, for ever! Considering an effective, noninvasive, do-no-harm product like Actipatch, it should have been embraced and shepherded into pain suffers' accessibility by the FDA long ago. But I think we all know what the score was in the past. So let's hope the FDA has come to its senses and will do the right thing soon. Ya know, if the FDA introduces more excuses in order to deny BIEL wide range clearance for its product, then maybe BIEL should consider suing them. The FDA can be sued, right? So, at least BIEL would get some national exposure, and maybe, just maybe, a little bit of justice.
Go! Go! Go! BIEL!!
GLTA!!!
Wonder why BIEL doesn't update its website! By not doing that it makes it appear they are running a 2-bit operation. Not Good! JMHO!
GLTA!!!
If the MMs are doing what you are accusing them of, isn't that fraud?
Yes, you're right, there are a little dreaming and wishful thinking going on here. But to get those metrics, to which you alluded, up and soaring your perspective customers must know you exist. Thus, if BIEL makes a plash as I so described in my previous post, that would be an advertisement of Super Nova status! That's all I'm saying! I also submit, it doesn't hurt to dream a little!
GO! BIEL!!
GLTA!!!
What if BIEL announced a day are two after the May 29th meeting, that the following three goals have been accomplished: Back Clearance (Done!), Dr. scholls deal (Got It!), RecoveryRx Clearance (Pretty Much Got that too!). Can one imagine the seismic upheaval within the analgesic world? You couldn't stop the stampede for this stock with a 2x4.
GLTA!!!
I agree! This is kinda strange considering all the recent fantastic news associated with BIEL, as of late. I would think we should be off to the races by now. But they say patience is a virtue, and I tend to agree. So... Go! BIEL!
GLTA!!!
I posted months ago that Allay was BIEL's sleeping giant, amongst the other outstanding products. I guess it's not so difficult to predict this one, considering the size of the target group, and the chronic frequency of dysmenorrhea, which effects it. Let's hope it receives expedited clearance!
GO! BIEL!!
GLTA!!!
The lack of updates as per the various mediums is, IMO, intentional. Thus, is a strategy being executed by BIEL. The reasoning for this escapes me, and I suppose most of us find it at lease curious. But nonetheless, BIEL is now beginning to pickup steam. So, let's relax and bare witness to what I think and hope will be a historical success story for BIEL.
Go! BIEL!!
GLTA!!!
Maybe "Daffy" is a better word for anybody who is even thinking about selling at this moment. ("Daffy" - A'la Miller's Crossing, check it out, great movie!)
GLTA!!!
Hey! 123, this is "DTL" giving you a shout-out here. Be it far from me to be the one to brace a defense of BIEL for lack of propagating timely shareholder updates. I've been attacked on this board by some, mercilessly for my so called "impatience".
But on this one, I think BIEL has it right on point. I think they are getting their ducks in a row, which may include the FDA providing some language within a pending PR, possibly. So, with all things considered, I think something BIG is ready to pop! I mean whammo! That's my Take!!
GLTA!!!
P.S. The Calm before the Storm!
Really! Prove it! Post The Link!
Yes, that makes sense "G". I also think it's possible that considerations developed during yesterdays meeting could have entrance criteria posed for the upcoming May 29th meeting. So, if there is a PR now being authored for yesterday's meeting, it would be measured in its scope. IMO!
I feel I must make the following point. Thus, anyone who sells BIEL stock at this point should be considered "Daffy", a'la "Miller's Crossing, not the Duck". Great Movie! Check It Out! The aforementioned descriptive term was not meant to insult but just to interject a little levity into this situation. But to be serious, let's hope the FDA does the right thing and sooner than later, issue a sweeping clearance for BIEL's products. That's My Take!!
GLTA!!!
There hasn't been any news released regarding yesterday's meeting, right? So, is it possible BIEL is waiting until after the May 29th meeting to release an all encompassing/comprehensive PR? Just a thought!
GLTA!!!
Well, why not?
I value and crave information, I guess you don't!
GLTA!!!
Who is the author of this article? Interesting! I've never heard of him/her. Great Stuff Though!!
GLTA!!!
Agreed! You got my point!
GLTA!!!
My goodness! What that heck is wrong with some "sheeple". Don't you want to know what's going on with the company in which your hard earned money is invested. If one is well informed, then there is less need to speculate. To possess factual, relevant, formation is always a plus, IMO. Furthermore, I would confidently posit that BIEL has an obligation to keep the shareholder informed, within a reasonable order of business. Isn't the shareholder part owner of the company, after all? However, you may have a different perspective regarding that concept. Excuse me!
GLTA!!!
JMHO, BIEL should produce a PR ASAP stating just what transpired during the meeting. It would be only fair to shareholders to do so. BIEL's officials know that their investors are waiting with bated breath to be informed about any development associated with the company. So BIEL be responsible and considerate and tell us what went on during that meeting! Us BIEL'ers want to know!
GLTA!!!
Have you heard anything from any politician regarding these new bio-E-wonders via to get market share? The answer is no!! WHY DO YOU THINK THAT IS? Because politicians know what side their bread is being buttered. There is a lot of cash in play here. Being caught with your hands in the proverbial cookie jar or not, the FDA rides guard on the cashbox, al'a the market. Like it, or not!
GLTA!!!
Hey, let's not sell the FDA short here! When it comes to business participation in the world of healthcare assisting devices and/or applied patient treatment, the FDA is the gatekeeper. Well, they are in this country anyway. If a company want's to apply their wares, in a serious way within that industry, they must negotiate
the FDA. Make no mistake about it. Sorry, that's just the way it is!!
GLTA!!! GO! BIEL!!!
P.S. The U.S. market is the #1 market, yes!!
If the FDA can't provide BIEL and the public, an acceptable medical reason why they are not issuing requested clearance by this company, then FDA should be petitioned, by the public, to do so.
GLTA!!!
If things go well at the FDA meeting today, there is no reason why an announcement expressing that fact shouldn't be reasonably prompt. Now if things go badly, then there might be some lag time with an announcement. You have to figure BIEL would have to regroup, formulate and announce a way-forward strategy for public consumption. They would have to try to protect their stock PPS, for the stock would suffer if the FDA tosses a goldbrick, once again. Look folks, the BIEL product is a game changer. Big Time! Without a doubt, its full introduction into the medical device application industry will cut into profits of some Big, Powerful competitors. IMO, they won't just stand by and accept this new-comer without positioning obstacles. But let's hope BIEL prevails.
GLTA!!!
Practically, the entire developed world has accepted BIEL's product as being highly efficacious. The countries of which I'm referring are not suspect in world standing, in regards to their laws and regulations. Thus, countries like, the U.K, Australia, Canada, and numerous others. But the FDA still holds out on issuing BIEL blanket clearance. As I have so stated in earlier posts... politics is no joke, especially dirty politics. Can anyone say lobbyist! Let's hope things work out well for all!!
GLTA!!!
Just what does this mean? Information is relevant only if context is associated with it.
GLTA!!!
We hear yah Rockk, but the metrics you are laying down are irrelevant/off base. The reason why there is a fallacy in your numbers/argument is because you are associating them with a company that's in its nascent stage of market development. BIEL doesn't advertise at all, relatively speaking. Therefore, most potential customers don't know BIEL, and/or it's products, even exist. So, until BIEL is up and standing steadily on it's sea legs, so to speak, we shouldn't expect to witness consistent market numbers associated with it. Furthermore, I submit it's not fair, nor constructive to presume BIEL will satisfy solid/consistent market metric at this stage in its development. But hopefully, in the near future, BIEL will meet those expectations in spades!
That's My Take!!
GLTA!!!, Go BIEL!!!
It's commendable to be super optimistic, but IMO it's going to take a while before we see a PPS number like that. Undoubtedly, we will have ebbs and flows, but by the end of the year maybe we will land somewhere around that figure. But that's ok, .05c is nothing to sneeze at. That would be a healthy gain by BIEL at this juncture of its
comprehensive growth trend. Go! Go! Go! BIEL!!!
GLTA!!!
No problem Bro!
"With the May 9 and May 29 upcoming meeting with the FDA, I will be amazed if ALLAY clearance by the FDA is discussed."
Well, why do you think Allay clearance will not be addressed during the upcoming meetings?
GLTA!!!
Sorry, made correction in bold red below... I'm with you on the potential of BIEL's staggering future success. Now, regarding the effects of a RS, yes, I understand that as well. Thus, A reverse stock split reduces the number of shares and increases the share price proportionately. A higher share price is usually good, but the increase that comes from a reverse split is mostly an accounting exercise. Granted! But my point was, in response to an earlier post, thus, if one owns a 100/1 ratio less stocks after a RS , then that's not a good thing. For instance, if the stock price in question is in an upward trajectory, the only way that shareholder could recover the proportionate value of lost shares is as follows: The future, PPS gains of each share would have to increase in intervals of the ratio of the RS in the other direction. Does that make sense folks? Maybe "The Lantern" is all wet today with that analogy. Well, I tried!
GLTA!!!
Go! Go! Go! BIEL!!!
I'm with you on the potential of BIEL's staggering future success. Now, regarding the effects of a RS, yes, I understand that as well. Thus, A reverse stock split reduces the number of shares and increases the share price proportionately. A higher share price is usually good, but the increase that comes from a reverse split is mostly an accounting exercise. Granted! But my point was, in response to an earlier post, thus, if one owns a hundred times less stocks after a RS , then that's not a good thing. For instance, if the stock price in question is in an upward trajectory, the only way that shareholder could recover the proportionate value of lost shares is as follows: The future, PPS gains of each share would have to increase in intervals of the ratio of the RS in the other direction. Does that make sense folks? Maybe "The Lantern" is all wet today with that analogy. Well, I tried!
GLTA!!!
Go! Go! Go! BIEL!!!
IMO, with a paradigm changing product as the Actipatch is, often there are difficult obstacles to negotiate before realizing your goal. Where BIEL is concern, IMO, there are some pretty formidable
political impediments that it must overcome; can anyone say big pharma lobbyist. It has been well established that the FDA is not immune to political influence. But nonetheless, let's hope for the best.
GLTA!!!
Go! BIEL!!
P.S. Beware! Politics ain't no joke, dirty politics in particular!
A 100/1 RS to arrive at, .03c to .05c, would be a big price to pay for shareholders. That RS ratio would wipe out a lot of people. IMO, not to rule out a RS, but to do it in a humane way. I'm not sure what that ratio should be, but BIEL should consider the loyal shareholders whom have hang in there for all these years, proving their support. That's My Take!!
GLTA!!!
Just what is this number? ..."600000000 according to Nasdaq"
To be clear, do you mean... $600M? Wow!
GLTA!!!
If the FDA does not give BIEL the "Green-light" on clearance at the upcoming meetings, it would be pretty clear the FDA is committing some serious goldbricking against BIEL. No Doubt It! IMHO! But hopefully, things will go well for BIEL at the meetings.
GLTA!!!
GO! Go! Go! BIEL!!!
Correction, as per my previous post: I should have referred to the U.S. Securities and Exchange Commission , not the justice dept.